Drug resistance in patients with leprosy in the United States.

Printer-friendly version
TitleDrug resistance in patients with leprosy in the United States.
Publication TypeJournal Article
AuthorsWilliams DL, Lewis C, Sandoval FG, Robbins N, Keas S, Gillis TP, Scollard DM
Abbrev. JournalClin. Infect. Dis.
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year of Publication2014
Volume58
Issue1
Pagination72-3
Publication Languageeng
KeywordsAnti-Bacterial Agents, Dapsone, DNA, Bacterial, Drug Resistance, Bacterial, Genes, Bacterial, Humans, Leprosy, Mycobacterium leprae, Polymerase Chain Reaction, Rifampin, Sequence Analysis, DNA, United States
Abstract

Molecular drug susceptibility testing was performed on 39 US patients with leprosy. Of these, 2 had dapsone-resistant Mycobacterium leprae and 1 of these patients also had rifampin-resistant M. leprae. Even though antileprosy drug resistance occurs in this leprosy population, resistance does not appear to be a major problem.

PubMed URL

http://www.ncbi.nlm.nih.gov/pubmed/24065328?dopt=Abstract

DOI10.1093/cid/cit628
Link to full texthttps://academic.oup.com/cid/article/58/1/72/372994